Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Market Cap : HK$6,404.3 Mil (As of Apr. 29, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's share price for the quarter that ended in Sep. 2023 was HK$2.57. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 1,043.0 Mil. Therefore, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's market cap for the quarter that ended in Sep. 2023 was HK$2,680.5 Mil.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's quarterly market cap declined from Dec. 2022 (HK$3,570.6 Mil) to Jun. 2023 (HK$2,684.7 Mil) and declined from Jun. 2023 (HK$2,684.7 Mil) to Sep. 2023 (HK$2,680.5 Mil).

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's annual market cap declined from Dec. 2021 (HK$4,015.6 Mil) to Dec. 2022 (HK$3,570.6 Mil) and declined from Dec. 2022 (HK$3,570.6 Mil) to Dec. 2023 (HK$2,659.7 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Enterprise Value for Today is HK$5,101.2 Mil.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Market Cap Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Market Cap Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

4,116.58

4,015.55

3,570.63

2,659.65

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															3,045.84	3,570.63	2,684.72	2,680.51	2,659.65

Competitive Comparison of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Market Cap falls into.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	HK$2.55	*	1043
	=	HK$2,659.7

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )	=	Share Price (Q: Sep. 2023 )	*	Shares Outstanding (EOP) (Q: Sep. 2023 )
	=	HK$2.57	*	1043
	=	HK$2,680.5

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

688505:China

Address

No. 308, Cai Lun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210

Website

http://www.fd-zj.com

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Headlines

No Headlines